Navigation Links
Researchers find first evidence of virus in malignant prostate cells
Date:9/7/2009

(SALT LAKE CITY) In a finding with potentially major implications for identifying a viral cause of prostate cancer, researchers at the University of Utah and Columbia University medical schools have reported that a type of virus known to cause leukemia and sarcomas in animals has been found for the first time in malignant human prostate cancer cells.

If further investigation proves the virus, XMRV (Xenotropic murine leukemia virus-related virus), causes prostate cancer in people, it would open opportunities for developing diagnostic tests, vaccines, and therapies for treating the cancer, according to the study published Sept. 7 online in the Proceedings of the National Academy of Sciences. Prostate cancer is expected to strike nearly 200,000 U.S. males this year, making it the second most common form of cancer, outside of skin cancers, among men.

"We found that XMRV was present in 27 percent of prostate cancers we examined and that it was associated with more aggressive tumors," said Ila R. Singh, M.D., Ph.D., associate professor of pathology at University of Utah and the study's senior author. "We still don't know that this virus causes cancer in people, but that is an important question we're going to investigate."

Singh, also a member of the U of U's Huntsman Cancer Institute and associate medical director at ARUP Laboratories, moved to Utah from Columbia University Medical Center in 2008, where she began this research. She remains an adjunct faculty member at Columbia.

Along with providing the first proof that XMRV is present in malignant cells, the study also confirmed that XMRV is a gammaretrovirus, a simple retrovirus first isolated from prostate cancers in 2006 by researchers at the University of California, San Francisco (UCSF), and the Cleveland Clinic. Gammaretroviruses are known to cause cancer in animals, but have not been shown to do so in humans. The UCSF study did not examine benign (non-malignant) p
'/>"/>

Contact: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Diabetes advance: Researchers find gene that causes resistance to insulin
2. Researchers find 2 more genetic risk factors for Alzheimers disease
3. Researchers restore missing protein in rare genetic brain disorder
4. Mayo Clinic researchers find that protein believed to protect against cancer has a Mr. Hyde side
5. Species diversity helps ASU researchers refine analyses of human gene mutations
6. UT Southwestern researchers examine mechanisms that help cancer cells proliferate
7. Marine biomedicine researchers decode structure of promising sea compound
8. Researchers report gene associated with language, speech and reading disorders
9. Bats use love songs during mating, researchers say
10. Idaho researchers win grant to explore DNA frontier
11. UCSF researchers identify 2 key pathways in adaptive response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 ...   Produktlinie mit DNA-Tests verbessert den Analyseprozess und ... QGEN ; Frankfurt Prime Standard: QIA) hat heute in ... Produktlinie Investigator ® für ... Die neuen Kits zur Erstellung genetischer Fingerabdrücke bieten eine ...
(Date:6/16/2015)... June 16, 2015 /CNW Telbec/ - handyem Inc. ... around the incorporation of handyem,s HPC-150 portable flow ... the Mo-POD™. This unprecedented model of mobile laboratory ... at the Pennsylvania Convention ... 15 th to 18 th 2015. ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3
... CLEAR Program is Back and Oberthur Technologies Remains a Key Partner -- CHANTILLY, Virginia, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
... SEATTLE, Wash. November 18, 2010 The Paul ... advance important neuroscience and cellular engineering research. The Allen ... and laboratories in Washington, California, Massachusetts and New York. ... paid over three years. "A year ...
... teaching space and Earth sciences, there,s a world of information ... K-12 teachers to bring it into the classroom. The ... grant to professors Paul Ruscher and Alejandro Gallard for a ... a series of courses to be offered to undergraduate and ...
Cached Biology News:The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 2The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 3The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 4The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 5The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 6The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 7The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 8The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 9First Allen Distinguished Investigators named 2First Allen Distinguished Investigators named 3FSU researchers helping K-12 teachers bring science down to Earth 2
(Date:6/30/2015)... June 30, 2015  Today, Americord Registry, one of the ... Andrew Horne , a partner at Kirkland & Ellis LLP, ... Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are ... Board," says Martin Smithmyer , CEO of Americord. "He ... career that will assist Americord,s growth and vision." ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares ... outstanding common shares (including shares of unvested restricted stock). On June 29, 2015, the ... price of Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , The ...
(Date:6/30/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company focused on the development of autologous cell ... Phase 1/2 clinical trial of RCT-01, being tested ... has been enrolled and their tissue biopsy sent ... is comprised of non-bulbar dermal sheath (NBDS) cells ...
(Date:6/30/2015)... ... June 30, 2015 , ... Cannavoices , Inc., ... unprecedented digital video and broadcast initiative. Produced by filmmakers, the multi-platform initiative aims ... legal medical cannabis stories ever assembled. , Cannavoices profiles Advocates, Patients, Entrepreneurs, ...
Breaking Biology Technology:Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3
... Wednesday, October,22, 2008, Wyeth (NYSE: WYE ) will ... will hold a one-hour conference call with,research analysts at ... and others may listen to the call live or ... be accessed by visiting our website,at http://www.wyeth.com ...
... Coleman to Lead Scientific Operations, NAPLES, Fla., ... ETHANOL(TM), the most advanced third generation biofuels,technology, today ... as Chief,Science Officer. Dr. Coleman, currently the Vice-Principal ... has over 20 years of,experience in the fields ...
... MEETING, Pa., Sept. 8 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: ... Company will present at the following conference:, ... the Grand Hyatt Hotel in Beijing on ... present at 10:20 AM local time. ...
Cached Biology Technology:Algenol Biofuels Appoints Chief Science Officer 2BMP Sunstone Announces Participation in September Investor Conference 2
MOUSE ANTI DUCK IgY LIGHT CHAIN...
Kit for Detection of Mitochondrial Membrane Potential...
For the quantitative determination of canine Interleukin 10,(IL-10) concentrations in cell culture supernates, canine serum,and plasma....
...
Biology Products: